Watts Gwilliam & Co., LLC Amgen Inc Transaction History
Watts Gwilliam & Co., LLC
- $474 Billion
- Q4 2024
A detailed history of Watts Gwilliam & Co., LLC transactions in Amgen Inc stock. As of the latest transaction made, Watts Gwilliam & Co., LLC holds 17,651 shares of AMGN stock, worth $5.49 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
17,651
Previous 17,523
0.73%
Holding current value
$5.49 Million
Previous $5.57 Billion
16.9%
% of portfolio
0.98%
Previous 1.21%
Shares
3 transactions
Others Institutions Holding AMGN
# of Institutions
3,172Shares Held
419MCall Options Held
8.25MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$16.4 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.3 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$9.15 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.52 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$4.1 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $166B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...